About Us
About Eugia
Our Values
Directors
Managment Team
Global Insignia
Our Capabilities
Research & Development
Facilities
Investors
Promoters
Reports & Policies
Portfolio
Overview
Key Therapeutic Areas
Sustainability
Overview
CSR
Media
Press Release
News and Updates
Blogs
Careers
Overview
Now Hiring
Contact
About Us
About Eugia
Our Values
Directors
Managment Team
Global Insignia
Our Capabilities
Research & Development
Facilities
Investors
Our Promoters
Reports & Policies
Portfolio
Overview
Key Therapeutic Areas
sustainability
Overview
CSR
Media
Press Release
News and Updates
Blogs
Careers
Overview
Now Hiring
Contact
PRESS RELEASES
Home
/
Media
/
Press Releases
2024-2025
2023-2024
2022-2023
2021-2022
2020-2021
Eugia Pharma receives USFDA approval for Dasatinib Tablets
April 23, 2025
Eugia Pharma receives USFDA approval for Pazopanib Tablets, 200 mg
December 5, 2024
Follow Us
Quick Links
About Us
Our Capabilities
Investors
Portfolio
Sustainability
Media
Privacy Policy
Get in touch
Contact
Careers
Copyright ©2025 Eugia Pharma. All Rights Reserved.
